ABAKUMOV et al.
1212
zol-3-yl]phenyl propionate (Vb). Yield 80 mg (50%),
mp 154°C, [α]D = –621.91°. IR spectrum, ν, cm–1:
3483, 3282, 2929, 2854, 2119, 1751, 1504, 1448,
1357, 1205, 1162. 1H NMR spectrum (CDCl3), δ, ppm:
1.39 m (8H, CH2), 1.64–1.87 m (4H, 4-H, 5-H),
1.76 m (4H, CH2), 2.55 m (4H, CH2), 2.79 s (3H,
NCH3), 2.80 m (1H, 3a-H), 3.26 m (1H, 6-H), 3.63 d
3
(1H, 3-H, J = 14.1 Hz), 6.99 s (1H, CH=C), 7.06 d
3
3
3
1.27 m (6H, CH3), 1.29 d (3H, CH3, J = 7.1 Hz),
(2H, Harom, J = 8.5 Hz), 7.08 d (2H, Harom, J =
3
1.64–1.88 m (4H, 4-H, 5-H), 2.59 m (4H, CH2), 2.79 s
(3H, NCH3), 2.80 m (1H, 3a-H), 3.26 m (1H, 6-H),
8.5 Hz), 7.35 d (2H, Harom, J = 8.5 Hz), 7.43 d (2H,
H
arom, 3J = 8.5 Hz). Found, %: C 75.18; H 8.21; N 5.20.
3
3.63 d (1H, 3-H, J = 14.0 Hz), 6.99 s (1H, CH=C),
C34H44N2O4. Calculated, %: C 74.97; H 8.14; N 5.14.
3
7.07 d (2H, Harom, J = 8.5 Hz), 7.09 d (2H, Harom
,
4-{(3S,3aR,6R,7E)-7-[4-(4-methoxybenzoyl)-
benzylidene]-2,6-dimethyl-3,3a,4,5,6,7-hexahydro-
2H-indazol-3-yl]phenyl 4-methoxybenzoate (Vf).
Compound IIIa, 0.40 mmol, was dispersed in 5 ml of
anhydrous THF, 45 mg (0.37 mmol) of 4-dimethyl-
aminopyridine was added, 0.38 g (2.40 mmol) of
p-methoxybenzoic acid was then added, the mixture
was cooled to 0°C (ice bath), and 0.50 g (2.40 mmol)
of N,N′-dicyclohexylcarbodiimide was added. The
mixture was stirred for 7 days and was treated as
described above. Yield 50 mg (24%), mp 150–151°C
(from DMF). IR spectrum, ν, cm–1: 2927, 2837, 1728,
3J = 8.5 Hz), 7.35 d (2H, Harom, J = 8.5 Hz), 7.44 d
3
3
(2H, Harom, J = 8.5 Hz). Found, %: C 73.23; H 7.08;
N 6.01. C28H32N2O4. Calculated, %: C 73.02; H 7.00;
N 6.08.
4-[(3S,3aR,6R,7E)-7-(4-Butanoyloxybenzylidene)-
2,6-dimethyl-3,3a,4,5,6,7-hexahydro-2H-indazol-
3-yl]phenyl butanoate (Vc). Yield 70 mg (42%),
mp 141–142°C, [α]D = –615.15°. IR spectrum, ν, cm–1:
2927, 2860, 1758, 1506, 1446, 1363, 1201, 1135.
1H NMR spectrum (CDCl3), δ, ppm: 1.05 m (6H,
CH3), 1.29 d (3H, CH3, 3J = 7.2 Hz), 1.64–1.88 m (4H,
4-H, 5-H), 1.79 m (4H, CH2), 2.54 m (4H, CH2), 2.79 s
(3H, NCH3), 2.80 m (1H, 3a-H), 3.26 m (1H, 6-H),
1
1604, 1512, 1255, 1203, 1162. H NMR spectrum
(CDCl3), δ, ppm: 1.32 d (3H, CH3, 3J = 7.1 Hz), 1.67–
3
1.91 m (4H, 4-H, 5-H), 2.83 s (3H, NCH3), 2.85 m
3.63 d (1H, 3-H, J = 14.1 Hz), 6.99 s (1H, CH=C),
3
3
(1H, 3a-H), 3.30 m (1H, 6-H), 3.67 d (1H, 3-H, J =
7.06 d (2H, Harom), 7.06 d (2H, Harom, J = 8.5 Hz),
7.08 d (2H, Harom, 3J = 8.5 Hz), 7.35 d (2H, Harom, 3J =
13.9 Hz), 3.90 s (6H, OCH3), 6.99 m (4H, Harom),
3
7.03 s (1H, CH=C), 7.19 d (2H, Harom, J = 8.6 Hz),
3
8.5 Hz), 7.44 d (2H, Harom, J = 8.5 Hz). Found, %:
7.22 d (2H, Harom, 3J = 8.6 Hz), 7.41 d (2H, Harom, 3J =
C 73.42; H 7.36; N 5.64. C30H36N2O4. Calculated, %:
C 73.74; H 7.43; N 5.73.
3
8.5 Hz), 7.49 d (2H, Harom, J = 8.5 Hz), 8.16 d (4H,
Harom, 3J = 8.8 Hz). Found, %: C 73.89; H 5.82; N 4.51.
4-[(3S,3aR,6R,7E)-2,6-Dimethyl-7-(4-pentanoyl-
oxybenzylidene)-3,3a,4,5,6,7-hexahydro-2H-inda-
zol-3-yl]phenyl pentanoate (Vd). Yield 50 mg (39%),
mp 125–126°C, [α]D = –553.46°. IR spectrum, ν, cm–1:
3465, 2927, 2856, 1745, 1504, 1446, 1201, 1141.
1H NMR spectrum (CDCl3), δ, ppm: 0.97 m (6H,
C38H36N2O6. Calculated, %: C 74.01; H 5.88; N 4.54.
The authors thank leading engineer I.V. Knyazeva
for her help in measuring mass spectra of some com-
pounds.
REFERENCES
3
CH3), 1.29 d (3H, CH3, J = 7.2 Hz), 1.45 m (4H,
1. Broer, D.J., Lub, J., and Mol, G.N., Nature, 1995,
CH2), 1.64–1.87 m (4H, 4-H, 5-H), 1.75 m (4H, CH2),
2.56 m (4H, CH2), 2.79 s (3H, NCH3), 2.80 m (1H,
vol. 378, p. 467.
3
2. Kozachenko, A., Sorokin, V., Kolomzarov, Yu., Nazaren-
ko, V., Zelinskii, R., and Titarenko, P., Proc. SPIE
ECLC’97, 1998, vol. 3318, p. 496.
3a-H), 3.26 m (1H, 6-H), 3.63 d (1H, 3-H, J =
3
14.0 Hz), 6.99 s (1H, CH=C), 7.06 d (2H, Harom, J =
3
8.5 Hz), 7.08 d (2H, Harom, J = 8.5 Hz), 7.35 d (2H,
3
3
3. Januszko, A., Kaszynski, P., and Drzewinski, W.,
Harom, J = 8.5 Hz), 7.43 d (2H, Harom, J = 8.5 Hz).
Found, %: C 74.70; H 7.85; N 5.47. C32H40N2O4. Cal-
culated, %: C 74.39; H 7.80; N 5.42.
J. Mater. Chem., 2006, vol. 16, p. 452.
4. Kutulya, L., Vashchenko, V., Semenkova, G., Shkolni-
kova, N., Drushlyak, T., and Goodby, J., Mol. Cryst. Liq.
Cryst., 2001, vol. 361, p. 125.
4-[(3S,3aR,6R,7E)-7-(4-Hexanoyloxybenzyli-
dene)-2,6-dimethyl-3,3a,4,5,6,7-hexahydro-2H-
indazol-3-yl]phenyl hexanoate (Ve). Yield 50 mg
(27%), mp 113–114°C, [α]D = –530.00°. IR spectrum,
ν, cm–1: 2925, 2860, 1747, 1504, 1452, 1355, 1201,
5. Lóránd, T., Kocsis, B., Emôdy, L., and Sohár, P., Eur. J.
Med. Chem., 1999, vol. 34, p. 1009.
6. Jagtap, P.G., Degterev, A., Choi, S., Keys, H., Yuan, J.,
Cuny G.D., J. Med. Chem., 2007, vol. 50, p. 1886.
1
1166, 1137. H NMR spectrum (CDCl3), δ, ppm:
7. Krapcho, J. and Turk, C.F., J. Med. Chem., 1979,
3
0.93 m (6H, CH3), 1.29 d (3H, CH3, J = 7.1 Hz),
vol. 22, p. 207.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 46 No. 8 2010